College Station, TX, United States of America

Surya Waghela

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Surya Waghela: Innovator in Viral Vaccine Technology

Introduction

Surya Waghela is a prominent inventor based in College Station, TX (US). He has made significant contributions to the field of vaccine technology, particularly in the development of innovative viral vaccine particles. With a total of 3 patents to his name, Waghela is recognized for his groundbreaking work that aims to enhance immune responses.

Latest Patents

One of Waghela's latest patents is the Mosaic Chimeric Viral Vaccine Particle. This invention describes compositions and methods for priming protective immunity in the presence of pre-existing maternal antibodies. In some embodiments, the invention contemplates simultaneously masking vaccines to avoid antibody neutralization while targeting those vaccines to specific cell types in order to elicit an enhanced immune response. Additionally, the invention includes vectors that recruit and activate specific antigen-presenting cells, which may further enhance the efficacy of those immune responses.

Career Highlights

Surya Waghela is affiliated with The Texas A&M University System, where he conducts his research and development work. His innovative approach to vaccine technology has positioned him as a key figure in the field, contributing to advancements that could significantly impact public health.

Collaborations

Waghela collaborates with notable colleagues, including Waithaka Mwangi and Luc Berghman. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise.

Conclusion

Surya Waghela's contributions to viral vaccine technology exemplify the importance of innovation in addressing health challenges. His work not only advances scientific knowledge but also holds the potential to improve vaccine efficacy and public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…